Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo controlled, phase 2 trial

  • S. E. Gitelman
  • , P. A. Gottlieb
  • , M. R. Rigby
  • , E. I. Felner
  • , S. M. Willi
  • , L. K. Fisher
  • , A. Moran
  • , M. Gottschalk
  • , W. V. Moore
  • , A. Pinckney
  • , L. Keyes-Elstein
  • , S. Aggarwal
  • , D. Phippard
  • , P. H. Sayre
  • , L. Ding
  • , J. A. Bluestone
  • , M. R. Ehlers

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo controlled, phase 2 trial'. Together they form a unique fingerprint.